These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 2816972)
1. Graves' disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms. Trzepacz PT; Klein I; Roberts M; Greenhouse J; Levey GS Am J Med; 1989 Nov; 87(5):558-61. PubMed ID: 2816972 [TBL] [Abstract][Full Text] [Related]
2. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis. Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274 [TBL] [Abstract][Full Text] [Related]
3. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis. Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731 [TBL] [Abstract][Full Text] [Related]
4. Age and stress as determinants of the severity of hyperthyroidism caused by Graves' disease in newly diagnosed patients. Vos XG; Smit N; Endert E; Brosschot JF; Tijssen JG; Wiersinga WM Eur J Endocrinol; 2009 Feb; 160(2):193-9. PubMed ID: 18974230 [TBL] [Abstract][Full Text] [Related]
6. Triiodothyronine production in Graves' hyperthyroidism. Woeber KA Thyroid; 2006 Jul; 16(7):687-90. PubMed ID: 16889493 [TBL] [Abstract][Full Text] [Related]
7. Serum triiodothyronine to thyroxine ratio: a newly recognized predictor of the outcome of hyperthyroidism due to Graves' disease. Takamatsu J; Kuma K; Mozai T J Clin Endocrinol Metab; 1986 May; 62(5):980-3. PubMed ID: 3754263 [TBL] [Abstract][Full Text] [Related]
8. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease and toxic multinodular goiter. Gedik O; Ozdemir T; Akalin S Isr J Med Sci; 1991 Jul; 27(7):361-4. PubMed ID: 1712765 [TBL] [Abstract][Full Text] [Related]
9. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease. Chen JJ; Ladenson PW J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547 [TBL] [Abstract][Full Text] [Related]
10. Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease. Takamatsu J; Sugawara M; Kuma K; Kobayashi A; Matsuzuka F; Mozai T; Hershman JM Ann Intern Med; 1984 Mar; 100(3):372-5. PubMed ID: 6546484 [TBL] [Abstract][Full Text] [Related]
11. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients. Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435 [TBL] [Abstract][Full Text] [Related]
12. Total serum thyroxine and triiodothyronine; a comparison between Graves' disease and hyperthyroxinaemia due to thyroxine replacement. Pearce CJ; Himsworth RL Acta Endocrinol (Copenh); 1984 Oct; 107(2):213-7. PubMed ID: 6548596 [TBL] [Abstract][Full Text] [Related]
14. Serum free thyroxine and triiodothyronine concentrations in subacute thyroiditis. Yoshida K; Sakurada T; Kaise N; Kaise K; Kitaoka H; Fukazawa H; Yamamoto M; Saito S; Yoshinaga K J Clin Endocrinol Metab; 1982 Jul; 55(1):185-8. PubMed ID: 6176591 [TBL] [Abstract][Full Text] [Related]
15. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission. Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661 [TBL] [Abstract][Full Text] [Related]
16. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content. Larsen PR J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364 [TBL] [Abstract][Full Text] [Related]
17. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism. Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819 [TBL] [Abstract][Full Text] [Related]
18. Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3). Chopra IJ; Williams DE; Orgiazzi J; Solomon DH J Clin Endocrinol Metab; 1975 Nov; 41(5):911-20. PubMed ID: 1242390 [TBL] [Abstract][Full Text] [Related]
19. The relationship of thyroxine turnover to other parameters of peripheral thyroid function in Graves' disease. Clifton-Bligh P; Burke G J Lab Clin Med; 1975 Jun; 85(6):922-33. PubMed ID: 48532 [TBL] [Abstract][Full Text] [Related]
20. Acute effects of corticosteroids on thyroid activity in Graves' disease. Williams DE; Chopra IJ; Orgiazzi J; Solomon DH J Clin Endocrinol Metab; 1975 Aug; 41(2):354-61. PubMed ID: 1174132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]